Kia ora koutou,
Welcome to the May Edition of the HealthTech Activator (HTA) Monthly Wrap!
Momentum is building across Aotearoa’s healthtech sector, and this month marks a significant shift. The announcement of strong government backing through Budget 2025 signals renewed national commitment to innovation and health delivery.
Alongside this, sector capability continues to grow through targeted initiatives like the HTA’s upcoming June workshops, these efforts are helping to build a strong foundation for innovation – complementing the governments bold investment and signalling a step-change for the sector.
Budget 2025 – A Record Investment in Health Delivery
The New Zealand Government’s 2025 Budget signals a decisive commitment to innovation and health delivery. A record $7 billion increase to Vote Health will strengthen core services and infrastructure, while also creating more space for growth in digital health, diagnostics, and medtech. Alongside this, a new 20% tax deduction for productive asset purchases is set to stimulate business investment, directly benefiting healthtech developers scaling their tools, systems, and technologies. Meanwhile, the launch of Invest New Zealand, as a new national investment attraction agency, further highlights the government’s recognition of technology, including health innovation, as a pillar of long-term economic strategy.
This national push towards improving health services aligns well with our next event: the Clinical Investigation Process for Medical Devices Workshop, happening 10–11 June in Auckland. Designed for startups, researchers, CROs, and sponsors, this two-day, in-person session will walk you through New Zealand’s ethics landscape, clinical trial setup, data quality, and regulatory requirements. The workshop is led by Julie Jones of BioValeo, a seasoned expert in clinical research across multiple trial phases and therapeutic areas. It’s the perfect place to get grounded in what you’ll need to generate and manage clinical evidence for global market access.
Register here by 2 June — spots are limited.
As always, we encourage you to explore the broader clinical validation resources available via the HTA platform. From ethics approval to operational oversight, we’re building the toolkit to support your clinical journey from idea to impact.
In a month where public investment is setting the stage for private innovation, there’s no better time to sharpen your strategy, build your clinical evidence, and connect with the support that can help you grow. Reach out to the HTA team — we’re here to help you take the next step.
Wishing you a productive and inspiring month ahead!
Clinical Investigation Process for Medical Devices workshop
Tuesday 10 June, 12:00pm - 5:00pm and Wednesday 11 June, 9:00am - 1:00pm, Auckland
Join us for a comprehensive workshop designed to enhance your understanding of the clinical investigation process, from planning and regulations to compliance and sponsor responsibilities. Led by Julie Jones of BioValeo, this workshop provides a comprehensive overview from planning and regulatory requirements (both NZ and international) to site start-up, trial conduct, quality oversight, compliance, sponsor responsibilities and trial close-out. Whether you're a researcher, sponsor, CRO, startup, or part of a site team, this workshop is ideal for anyone involved in the clinical trial process. If you need clinical data to support market access, this training is designed for you.
Commercial Strategy & Planning
Tuesday 17 June, 9am - 5pm, Auckland
Navigating health tech supply chains is challenging. This workshop equips you with essential commercial planning and strategy insights to chart your journey to success. Led by Dan Hansen, director of consulting firm Apagie, and CEO of AVRT Group, this workshop is ideal for early-stage companies planning for their future market entry.
New Webinar: Unlocking Value in the US Market - A Health Economics Overview
Demonstrating value is just as important as generating evidence. If you missed it, our recent webinar Unlocking Value in the US, led by Abbas Al-Murrani and a panel of US experts, explores how health economics supports smarter decision-making and successful commercialisation strategies in complex healthcare systems. Watch the recording here - HTA Health & Economics Webinar.
